Nemaura Medical Inc. [NASDAQ: NMRD] closed the trading session at $9.78 on 02/08/21. The day’s price range saw the stock hit a low of $8.38, while the highest price level was $12.59. The company report on February 4, 2021 that Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing.
Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces the appointment of Thomas Mortensen as head of E.U. commercial operations and marketing.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
“Tom is an important addition to our team, as he will head up our operations in the E.U for our planned direct to consumer product. His extensive experience throughout Europe will help us determine the best way to position our products for country-specific audiences, and we look forward to his leadership and guidance as we ramp up our marketing activities,” said Faz Chowdhury, Ph.D., Nemaura’s CEO.
The stocks have a year to date performance of 159.42 percent and weekly performance of 102.07 percent. The stock has been moved at 69.79 percent over the last six months. The stock has performed 150.77 percent around the most recent 30 days and changed 167.95 percent over the most recent 3-months.
If compared to the average trading volume of 79.72K shares, NMRD reached to a volume of 6233093 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Nemaura Medical Inc. [NMRD]:
The Average True Range (ATR) for Nemaura Medical Inc. is set at 0.89 The Price to Book ratio for the last quarter was 19.56, with the Price to Cash per share for the same quarter was set at 0.72.
NMRD stock trade performance evaluation
Nemaura Medical Inc. [NMRD] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 102.07. With this latest performance, NMRD shares gained by 150.77% in over the last four-week period, additionally plugging by 69.79% over the last 6 months – not to mention a rise of 214.10% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for NMRD stock in for the last two-week period is set at 85.06, with the RSI for the last a single of trading hit 88.81, and the three-weeks RSI is set at 81.76 for Nemaura Medical Inc. [NMRD]. The present Moving Average for the last 50 days of trading for this stock 4.45, while it was recorded at 7.22 for the last single week of trading, and 5.54 for the last 200 days.
Nemaura Medical Inc. [NMRD]: An insightful look at the core fundamentals
Return on Total Capital for NMRD is now -1,045.67, given the latest momentum, and Return on Invested Capital for the company is -910.37. Return on Equity for this stock declined to -910.37, with Return on Assets sitting at -139.05.
Reflecting on the efficiency of the workforce at the company, Nemaura Medical Inc. [NMRD] managed to generate an average of -$244,717 per employee.Nemaura Medical Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.00 and a Current Ratio set at 6.10.
Nemaura Medical Inc. [NMRD]: Insider Ownership positions
There are presently around $15 million, or 6.70% of NMRD stock, in the hands of institutional investors. The top three institutional holders of NMRD stocks are: SABBY MANAGEMENT, LLC with ownership of 613,765, which is approximately New of the company’s market cap and around 61.69% of the total institutional ownership; BLACKROCK INC., holding 366,195 shares of the stock with an approximate value of $3.58 million in NMRD stocks shares; and VANGUARD GROUP INC, currently with $1.39 million in NMRD stock with ownership of nearly -13.987% of the company’s market capitalization.
Positions in Nemaura Medical Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 15 institutional holders increased their position in Nemaura Medical Inc. [NASDAQ:NMRD] by around 780,864 shares. Additionally, 9 investors decreased positions by around 60,765 shares, while 9 investors held positions by with 699,170 shares. The mentioned changes placed institutional holdings at 1,540,799 shares, according to the latest SEC report filing. NMRD stock had 7 new institutional investments in for a total of 729,560 shares, while 2 institutional investors sold positions of 24,869 shares during the same period.